The Use of IGF-I to Monitor Long-Acting Growth Hormone Therapy-Timing is an Art…

J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2367-e2369. doi: 10.1210/clinem/dgab016.
No abstract available

Keywords: biomarker; dose adjustment; growth hormone deficiency; pharmacodynamics; safety.

Publication types

  • Comment

MeSH terms

  • Growth Hormone
  • Human Growth Hormone*
  • Humans
  • Insulin-Like Growth Factor I
  • Monitoring, Physiologic
  • Pituitary Hormones, Anterior*

Substances

  • Pituitary Hormones, Anterior
  • Human Growth Hormone
  • Insulin-Like Growth Factor I
  • Growth Hormone